Zydus Group Lifesciences is moving forward with its planned acquisition of a controlling 85.6% stake in French orthopaedic technology firm Amplitude Surgical SA for approx. ₹2,430 crore (€256.8 million). As part of the transaction, the company has incorporated a wholly-owned subsidiary in France — Zydus MedTech (France) SAS. According to a regulatory filing, the acquisition marks a key milestone in Zydus’ broader strategy to expand its international footprint and diversify into the global medical technology space.

Amplitude Surgical is a leading player in orthopaedic solutions, specialising in lower limb reconstructive surgery. With a strong presence across Europe, the company distributes its products in over 30 countries.

Sharvil Patel, Managing Director of Zydus Lifesciences, noted that the acquisition represents a strategic entry into the fast-growing orthopaedic devices market and aligns with the company’s vision of building a diversified healthcare portfolio.

Commenting on the development, Olivier JALLABERT, CEO and founder of Amplitude Surgical, said, “The Amplitude Surgical team and I are delighted to join Zydus.”

Once completed, the transaction will enable Zydus to leverage Amplitude’s innovation capabilities and established distribution network. It also underscores Zydus’ intent to move beyond its core pharmaceutical business and strengthen its presence in high-growth verticals such as medtech and orthopaedics.

The deal remains subject to regulatory approvals and customary closing conditions.

Thank you for your thoughtful nomination.

At CORPORATE TRENDZ, we are committed to recognizing excellence and dedication. By submitting this nomination, you have shone a light on an individual of exceptional vision, helping to showcase their outstanding contributions.

Our panel will review your submission. A member of our team will contact you shortly to provide guidance on the subsequent steps.

Meet Past Winners: Get inspired by the stories of our previous honorees. Read Their Stories Here